Aemetis Stock Price, News & Analysis

Aemetis, Inc. (NASDAQ: AMTX) announced its subsidiary, Aemetis Properties Riverbank, has acquired a 20% stake in Nevo Motors, Inc. under a strategic agreement aimed at electric vehicle production. This partnership will leverage Aemetis' manufacturing facilities and renewable energy resources, targeting the launch of Nevo's heavy-duty electric trucks in Q1 2021. The trucks will utilize patented range extender generators powered by renewable natural gas, with the goal of reducing emissions and costs in the $90 billion trucking industry.

Aemetis, Inc. (NASDAQ: AMTX) has secured a $24 million initial purchase order for sanitizer alcohol and nitrile gloves through its subsidiary, Aemetis Health Products. This agreement with a California distributor aims to supply health safety products across various governmental and healthcare entities in the U.S.

With its plant reportedly becoming the largest sanitizer alcohol producer in the Western U.S., Aemetis is expanding its product line to include nitrile gloves, leveraging its extensive experience in Asian markets. A credit facility has been negotiated to support these health safety product transactions.

Aemetis, Inc. (NASDAQ: AMTX) announced that its subsidiary, Aemetis Biogas LLC, received $7.8 million in grants from the California Department of Food and Agriculture's DDRDP, equating to nearly 50% of the total funds awarded. This funding supports the installation of dairy digesters to produce renewable natural gas, expected to eliminate 2.6 million metric tons of CO2 and generate over 100 jobs. The company plans to accelerate the construction of 16 additional digesters and a biogas facility, aiming for RNG injection into PG&E’s pipeline by Q1 2021.

Aemetis, Inc. (NASDAQ:AMTX) reported its financial results for Q3 2020, showing revenues of $40.9 million, down from $57.4 million in Q3 2019. The net loss was $12.2 million, compared to $7.2 million the previous year. Ethanol and high-grade alcohol sales increased by 11%, while biodiesel sales surged 216% compared to Q2 2020. The company achieved milestones in its dairy biogas project and launched Aemetis Health Products to meet sanitizer demand. Total revenues for the first nine months of 2020 were $128.2 million, an 14.6% decline from 2019.

Aemetis, Inc. (NASDAQ: AMTX) will host a conference call to discuss its third quarter 2020 earnings report on November 12, 2020, at 11 am PST. Interested parties can participate via toll-free and international dial-in numbers or through a webcast available on the company's website. The earnings report will be accessible after November 19, 2020, for further review. Aemetis is engaged in renewable fuels and biochemical technologies, operating facilities in California and India, with a focus on converting traditional petroleum products into advanced biorefineries.

Aemetis, Inc. (NASDAQ: AMTX) has initiated production of dairy biogas from two dairies as part of a larger 17-dairy biogas project. This below-zero carbon intensity gas is being used for ethanol production at the Aemetis facility in California. The company plans to scale up its operations, adding 15 more digesters and related infrastructure. The funding plan for this project includes over $65 million in preferred equity and grants. This initiative provides a new revenue stream for local dairies and meets California's methane emission reduction goals.

Aemetis, Inc. (NASDAQ: AMTX) has initiated production of hand sanitizer under its Aemetis Health Products label, targeting government and consumer markets. The company's California facility is noted as the largest hand sanitizer alcohol producer in the Western U.S., eliminating long transport times for sanitizer products. Aemetis hand sanitizer contains 70% to 80% alcohol, meeting FDA standards. The company aims to provide safe, domestic products while supporting U.S. jobs and addressing the demand for sanitizer.

Aemetis, Inc. (NASDAQ: AMTX) has successfully closed its Phase I EB-5 Program, raising $35.5 million from 71 foreign investors. The funds will generate direct and indirect jobs at its ethanol plant in California. All investors have been vetted by the U.S. Department of Homeland Security and granted conditional permanent residency. Aemetis plans to initiate a Phase II offering, targeting an additional $50 million to create approximately 2,000 jobs for 200 investors. The project has gained National Interest Expedite (NIE) approval for expedited processing of investor applications.

Aemetis (NASDAQ: AMTX) announced FDA approval for the production and marketing of Over The Counter sanitizer products through its subsidiary, Aemetis Health Products. This registration allows Aemetis to meet the rising demand for hand sanitizers and related products during the COVID-19 pandemic, positioning the company as a unique large-scale sanitizer alcohol producer in the Western U.S. The global hand sanitizer market was valued at approximately $2.9 billion in 2019 and has seen significant growth due to the pandemic.